BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA)

Historical Holders from Q3 2024 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.00001 per share
Symbol
BIOA on Nasdaq
Shares outstanding
35,872,648
Price per share
$13.24
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
21,259,082
Total reported value
$125,003,330
% of total 13F portfolios
0%
Share change
+518,828
Value change
+$3,516,036
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
92
Price from insider filings
$12.85
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Cormorant Asset Management, LP 6% -20% $10,274,904 -$2,346,835 2,140,605 -19% Cormorant Asset Management, LP 30 Jun 2025
ADAR1 Capital Management, LLC 5.4% $9,298,190 1,937,123 ADAR1 Capital Management, LLC 30 Jun 2025
RA CAPITAL MANAGEMENT, L.P. 3.7% $4,822,968 1,310,589 RA Capital Management, L.P. 31 Dec 2024
As of 30 Sep 2025, BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) has 92 institutional shareholders filing 13F forms. They hold 21,259,082 shares. of 35,872,648 outstanding shares (59%) .

Top 25 institutional shareholders own 56% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
a16z Capital Management, L.L.C. 9% 3,233,170 0% 1.4% $19,011,040
Sofinnova Investments, Inc. 6.4% 2,293,788 -0.48% 0.83% $13,487,473
Cormorant Asset Management, LP 6% 2,140,605 0% 0.87% $12,586,757
ADAR1 Capital Management, LLC 5.2% 1,880,073 -2.9% 1.1% $11,054,829
VANGUARD GROUP INC 4.6% 1,651,247 +6% 0% $9,709,331
TANG CAPITAL MANAGEMENT LLC 4.5% 1,600,000 0% 0.36% $9,408,000
BlackRock, Inc. 3.6% 1,279,621 -0.61% 0% $7,524,172
ORBIMED ADVISORS LLC 2.2% 790,901 -14% 0.11% $4,650,498
Sands Capital Alternatives, LLC 2.2% 786,353 0% 1% $4,623,756
Pivotal bioVenture Partners Investment Advisor LLC 1.8% 653,374 0% 2.2% $3,841,839
GEODE CAPITAL MANAGEMENT, LLC 1.6% 562,731 +24% 0% $3,310,050
REDPOINT MANAGEMENT, LLC 1.1% 383,254 0% 1.4% $2,253,534
Siren, L.L.C. 1.1% 382,406 0% 0.09% $2,248,547
MILLENNIUM MANAGEMENT LLC 0.85% 306,552 +750% 0% $1,802,526
Comprehensive Financial Management LLC 0.76% 271,842 0% 0.04% $1,598,431
MORGAN STANLEY 0.64% 228,158 +6.9% 0% $1,341,569
JACOBS LEVY EQUITY MANAGEMENT, INC 0.59% 213,088 -22% 0% $1,252,957
STATE STREET CORP 0.55% 198,111 +23% 0% $1,164,893
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.53% 191,383 +59% 0% $1,125,332
Stonepine Capital Management, LLC 0.53% 188,571 +25% 0.9% $1,108,797
NORTHERN TRUST CORP 0.52% 186,568 +22% 0% $1,097,020
MARSHALL WACE, LLP 0.49% 174,196 -23% 0% $1,024,272
RENAISSANCE TECHNOLOGIES LLC 0.4% 143,000 +60% 0% $840,840
LOS ANGELES CAPITAL MANAGEMENT LLC 0.34% 120,929 0% $711,063
CITADEL ADVISORS LLC 0.32% 114,063 +4.1% 0% $670,690

Institutional Holders of BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 80 $1,059 1,323.75% 1
2025 Q3 21,259,082 $125,003,330 +$3,516,036 588% 92
2025 Q2 20,716,454 $85,559,284 +$3,327,575 413% 81
2025 Q1 20,278,591 $76,156,877 +$1,658,485 376% 65
2024 Q4 19,640,328 $113,715,467 -$68,469,643 579% 63
2024 Q3 20,669,688 $429,942,211 +$423,556,876 2,080% 57